Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,212 total articles
Spyre Therapeutics announced the launch of its SPY772 program, a dual long-acting antibody combination targeting TL1A and IL-17A/F for Hidradenitis Suppurativa (HS). The company has initiated the randomized Phase 2 SKYLIGHT trial to evaluate the clinical proof-of-concept of this dual inhibition approach, aiming to improve efficacy and convenience o…
California Resources Corporation (NYSE: CRC) announced an agreement to acquire Crimson Midstream Holdings for approximately $63 million to strengthen its integrated midstream energy infrastructure platform in California. The acquisition includes about 2,000 miles of pipelines with capacity of 400 thousand barrels per day, improving CRC's ability to…
Standard Lithium Ltd. reported strong second quarter 2026 results, marked by completion of major milestones including receiving a Finding of No Significant Impact (FONSI) from the U.S. Department of Energy under NEPA for its South West Arkansas Project (SWA Project), and execution of two critical construction contracts. These achievements position …
Alvotech, a global biotechnology company specializing in biosimilar medicines, will report its financial results for the first half of 2026 on August 19, followed by a webcast and live Q&A on August 20. The company focuses on developing and manufacturing biosimilars and has multiple products approved and marketed globally, with strategic partnershi…
Rani Therapeutics Holdings, a clinical-stage biotherapeutics company focused on oral delivery of biologics, announced that its management team will participate in the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026. The company will present and hold one-on-one meetings to discuss its proprietary oral biologics delivery platform, …
Telomir Pharmaceuticals announced publication of peer-reviewed preclinical data demonstrating their drug candidate Telomir-Zn suppresses tumor growth in triple-negative breast cancer (TNBC) and prostate cancer models by modulating intracellular iron and copper to inhibit KDM histone demethylases. The selective targeting of iron-dependent cancer cel…
Credicorp Ltd., a leading Peruvian financial services holding company listed on the NYSE as BAP, announced its earnings release for the second quarter of 2026 scheduled for August 13, with a follow-up conference call on August 14 featuring key executives. The company also referenced its recently filed 2025 Annual Report with audited financials unde…
Cogent Biosciences reports significant progress in 2026 including the submission of multiple New Drug Applications for bezuclastinib targeting Gastrointestinal Stromal Tumors (GIST) and Systemic Mastocytosis, a strong cash position of $865.9 million, and full onboarding of a specialized commercial team ahead of potential FDA approvals later this ye…
CoreCivic, Inc. has entered into a $500 million accelerated share repurchase agreement as part of its expanded $755.8 million share repurchase program. The transaction is expected to reduce weighted average shares outstanding, enhancing per share metrics. Following the ASR agreement, CoreCivic updated its 2026 financial guidance, raising diluted EP…
Aether Holdings, Inc. announced the acquisition of a 60% interest in Noviant, a technology services company with expertise in enterprise infrastructure, cloud, cybersecurity, and managed IT services. This acquisition strengthens Aether Compute's AI infrastructure strategy by integrating Noviant's deployment, management, and support services, positi…
XPO, Inc., a leading North American freight transportation company, has appointed Jonas Svedlund as its new Chief Legal Officer. Svedlund brings significant legal expertise from his previous roles at Thermo Fisher Scientific and General Electric, and will oversee legal, compliance, corporate governance, and commercial matters at XPO.
Autozi Internet Technology's Hong Kong subsidiary intends to acquire significant economic exposure to SpaceX through a fund or similar vehicle as a strategic treasury asset. The transaction is pending due diligence, financing, and approvals. Autozi aims to enhance shareholder value by diversifying into innovative global technology assets like Space…
Oruka Therapeutics announced solid second quarter financial results with a strong cash position of $1.1 billion, enabling funding through a Biologics License Application (BLA) filing for ORKA-001. The company advanced key clinical programs including positive Phase 2a data for ORKA-001 in plaque psoriasis, full enrollment in EVERLAST-B Phase 2b tria…
Bitdeer Technologies Group disclosed its unaudited financial results for Q2 2026 with total revenue increasing substantially to $228.8 million driven by major growth in self-mining and AI cloud segments. Despite higher revenues, the company experienced a gross loss of $8.5 million and a net loss of $92.3 million, impacted by rising electricity cost…
Kaspi.kz announced robust 2Q and 1H 2026 financial results with strong growth in e-Commerce, Payments, and Fintech segments. The company launched Kasper, a personal AI shopping assistant, seeing rapid user adoption, and declared an 18% increase in quarterly dividends. Kaspi.kz also completed the acquisition of Rabobank A.Ş. in Türkiye to expand its…
Tenax Therapeutics announced topline results from its Phase 3 LEVEL trial evaluating oral levosimendan (TNX-103) in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF). The study did not meet its primary endpoint of improvement in 6-minute walk distance or the key secondary endpoint of symp…
Grifols announced the completion of the clinical portion of its SPARTA Phase 3 trial evaluating two dosage regimens of Prolastin®-C in patients with emphysema caused by alpha-1 antitrypsin deficiency (AATD). The trial enrolled 345 patients across 16 countries and utilized lung CT densitometry as the primary endpoint. The results are expected by the…
Tonix Pharmaceuticals Holding Corp. reported a significant 197% increase in net sales of TONMYA in Q2 2026, reaching approximately $11 million. Coverage now includes about 136 million U.S. lives, with further expansion expected in managed Medicare starting January 2027. The company initiated a Phase 2 study for TNX-102 SL in major depressive disord…
Jade Biosciences announced encouraging second quarter 2026 financial results and significant clinical updates including positive interim Phase 1 data for JADE101 in IgA nephropathy, initiation of Phase 2 and planned Phase 3 trials, and progress with JADE201 and JADE301 programs targeting autoimmune diseases. The company reported a robust cash posit…
Ceribell, Inc., a medical technology firm specializing in neurological diagnostics, announced FDA 510(k) clearance for two new AI-driven features—Epileptiform Abnormality Detection and Artifact Reduction—integrated into its cloud-based Neurology Portal. These enhancements improve the accuracy and efficiency of EEG evaluations in critical care setti…
Veru Inc. reported its fiscal third quarter 2026 financial results, highlighting full enrollment of 239 patients in its Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide for high quality weight loss in older obese patients. The company entered a clinical supply agreement with Novo Nordisk and received a USPTO noti…
Aeries Technology, Inc. reported strong first-quarter fiscal 2027 results with a 43% year-over-year revenue increase to $21.9 million, significant improvements in profitability, and operating cash flow of $4.8 million. The company reaffirmed its fiscal year 2027 guidance and launched AxAI, an agentic AI solution, expanding its AI transformation str…
Ryman Hospitality Properties, Inc. announced a definitive agreement to acquire Grande Lakes Orlando Resort for $1.38 billion. The purchase includes two luxury hotels and an 18-hole golf course, operated by Marriott International. This acquisition aligns with the company's strategy to expand its upscale convention center resorts and is expected to b…
TJGC Group Limited announced it is negotiating a potential non-exclusive, worldwide intellectual property license agreement with a robotics technology provider to commercialize certain AI and robotics technologies. The agreement, if finalized, would support TJGC's intelligent automation strategy and technology portfolio expansion. However, there is…
Barrick Mining Corporation and Newmont Corporation have reached an agreement to amend their Nevada Gold Mines joint venture by contributing previously excluded properties and resolving all outstanding disputes. Newmont will compensate Barrick with $1.95 billion for property contributions and has consented to Barrick's planned IPO of its North Ameri…
